No Data
No Data
No Data
No Data
No Data
Know Labs Price Target Announced at $1.00/Share by Benchmark
Know Labs Price Target Announced at $1.00/Share by Benchmark
Dow JonesApr 8 20:14
Know Labs Initiated at Speculative Buy by Benchmark
Know Labs Initiated at Speculative Buy by Benchmark
Dow JonesApr 8 20:14
Know Labs (KNW.US) was first covered by Benchmark, which gave it a Speculative Buy rating, with a target price of $1.00.
Know Labs (KNW.US) was first covered by Benchmark, which gave it a Speculative Buy rating, with a target price of $1.00.
Zhitong FinanceApr 8 20:10
Benchmark Initiates Coverage On Know Labs With Speculative Buy Rating, Announces Price Target of $1
Benchmark analyst Bruce Jackson initiates coverage on Know Labs with a Speculative Buy rating and announces Price Target of $1.
Analyst UpgradesApr 8 20:03
Know Labs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/08/2024 56.01% Benchmark → $1 Initiates Coverage On → Speculative Buy
BenzingaApr 8 20:02
Know Labs to Present Clinical Research at the 2024 American Physiology Summit
The Company demonstrates significant progress since presenting at last year's Summit. Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been
BusinesswireApr 5 21:00
No Data
No Data